LONDON Oct 22 AstraZeneca and Eli Lilly said on Thursday they were deepening their collaboration in cancer immunotherapy by testing new drug combinations for treating solid tumours.
Lilly will lead the studies, while both companies will contribute resources. Details of financial arrangements and tumours to be studied were not disclosed.
14:38 Tesla buyers banned from ride-sharing with their vehicles6
11:10 Merged BAT-Reynolds could be loaded with up to $55 billion of debt, analysts say6
11:25 Every Tesla car will contain the hardware to drive itself2
00:20 Tesla Says All Vehicles in Production Capable of Self-Driving2